HCA HEALTHCARE, INC.

(HCA)
  Report
Delayed Nyse  -  05/27 04:00:02 pm EDT
215.55 USD   +1.78%
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare...
05/27Bernstein Upgrades HCA Healthcare to Outperform From Market Perform; Price Target is $271
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA HEALTHCARE, INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

01/27/2022 | 08:21am EDT

Item 2.02. Results of Operations and Financial Condition.

On January 27, 2022, HCA Healthcare, Inc. (the "Company") issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2021, the text of which is set forth as Exhibit 99.1.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 24, 2022, the Company's Board of Directors (the "Board"), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Andrea B. Smith to the Company's Board effective January 26, 2022, increasing the number of directors on the Board from 10 to 11. Ms. Smith will serve on the Board's Audit and Compliance Committee and Patient Safety and Quality of Care Committee.

Ms. Smith was appointed to the Board pursuant to the Company's Amended and Restated Certificate of Incorporation, which provides that a majority of directors on the Board may determine the number of directors which shall constitute the Board and that the Board may fill a newly created directorship resulting from any increase in the number of directors on the Board. There is no arrangement or understanding between Ms. Smith and any other person pursuant to which Ms. Smith was selected as a director on the Board, nor is Ms. Smith a member of the family of any executive officer of the Company or of any other director on the Board. There have been no transactions, proposed or otherwise, in which Ms. Smith participated or will participate that would be required to be disclosed herein pursuant to Item 404(a) of Regulation S-K. Ms. Smith will participate in the compensation program the Company maintains for its non-management directors, which compensation program was described in the Proxy Statement the Company filed with the Securities and Exchange Commission on March 19, 2021.

A copy of the press release issued by the Company announcing Ms. Smith's appointment to the Board is attached hereto as Exhibit 99.2 and incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On January 27, 2022, the Company issued a press release announcing, among other matters, its results of operations for the fourth quarter and year ended December 31, 2021, the text of which is set forth as Exhibit 99.1.

Item 8.01. Other Events.

On January 27, 2022, the Company announced that its Board of Directors had authorized an additional share repurchase program for up to $8 billion of the Company's outstanding common stock. Repurchases will be made in accordance with applicable securities laws from time to time in the open market, through privately negotiated transactions, or otherwise.

On January 27, 2022, the Company also announced that its Board of Directors had declared a quarterly cash dividend of $0.56 per share of the Company's common stock. The dividend will be paid on March 31, 2022 to stockholders of record at the close of business on March 17, 2022.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:



Exhibit 99.1      Press Release, dated January 27, 2022

Exhibit 99.2      Press Release, dated January 26, 2022

Exhibit 104     Cover Page Interactive Data File (embedded within the Inline XBRL
                document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about HCA HEALTHCARE, INC.
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
05/27Bernstein Upgrades HCA Healthcare to Outperform From Market Perform; Price Target is $2..
MT
05/26HCA HEALTHCARE, INC. : Other Events (form 8-K)
AQ
05/24HCA Healthcare Announces HCA Healthcare Foundation's $1.38 Million Grant to Girl Scouts
BU
05/18TRANSCRIPT : HCA Healthcare, Inc. Presents at RBC Capital Markets Global Healthcare Confer..
CI
05/16Keith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division; HCA Health..
AQ
05/13Keith Zimmerman Appointed President of HCA Healthcare's MidAmerica Division
BU
05/13HCA Healthcare, Inc. Appoints Keith Zimmerman as President of the Company’s Kansas..
CI
05/11TRANSCRIPT : HCA Healthcare, Inc. Presents at Bank of America 2022 Healthcare Conference, ..
CI
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations